Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$11.52
$11.50
$5.57
$11.98
$397.94M1.11106,940 shs9,831 shs
BCV
Bancroft Fund
$14.96
-0.4%
$15.46
$14.09
$18.11
$87.79M0.9824,592 shs8,564 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
0.00%0.00%0.00%0.00%0.00%
BCV
Bancroft Fund
-0.43%+1.46%-5.65%-1.74%+1,495,499,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/AN/AN/AN/A
BCV
Bancroft Fund
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/A
BCV
Bancroft Fund
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$822.52M0.48$1.69 per share6.80$2.59 per share4.45
BCV
Bancroft Fund
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/A
BCV
Bancroft Fund
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/A
BCV
Bancroft Fund
$1.288.56%-25.69%N/AN/A

Latest TGF, BCV, SHED, and ARA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/14/2024
BCV
Bancroft Fund
Quarterly$0.328.08%3/13/20243/14/20243/21/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
7.54
1.05
1.02
BCV
Bancroft Fund
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
78.42%
BCV
Bancroft Fund
22.43%

Insider Ownership

CompanyInsider Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
9.50%
BCV
Bancroft Fund
4.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
4,97734.54 millionN/AOptionable
BCV
Bancroft Fund
N/A5.87 million5.63 millionNot Optionable

TGF, BCV, SHED, and ARA Headlines

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

American Renal Associates logo

American Renal Associates

NYSE:ARA
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.

Bancroft Fund

NYSE:BCV
Bancroft Fund Ltd. is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. It is managed by Gabelli Funds, LLC. The fund invests in the public equity markets. It primarily invests in convertible securities including convertible debt and convertible preferred stocks. The fund invests in stocks of companies across market capitalization. It benchmarks the performance of its portfolio against S&P 500 Index, Bank of America Merrill Lynch All U.S. Convertibles Index, and Barclays Balanced U.S. Convertibles Index. The fund was formerly known as Bancroft Convertible Fund, Inc. Bancroft Fund Ltd. was formed on April 20, 1971 and is domiciled in the United States.